Unleashing the power of generative AI in drug discovery
Author:
Funder
Governo Italiano Ministero dell'Istruzione dell'Universita e della Ricerca
Publisher
Elsevier BV
Reference160 articles.
1. Innovation in the pharmaceutical industry: new estimates of R&D costs;DiMasi;J Health Econ,2016
2. Estimated research and development investment needed to bring a new medicine to market, 2009–2018;Wouters;JAMA,2020
3. High-throughput screening: today’s biochemical and cell-based approaches;Blay;Drug Discov Today,2020
4. Virtual screening strategies in drug discovery: a critical review;Lavecchia;Curr Med Chem,2013
5. Software for molecular docking: a review;Pagadala;Biophys Rev,2017
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Navigating the frontier of drug-like chemical space with cutting-edge generative AI models;Drug Discovery Today;2024-09
2. Current strategies to address data scarcity in artificial intelligence-based drug discovery: A comprehensive review;Computers in Biology and Medicine;2024-09
3. Generative artificial intelligence in chemical engineering spans multiple scales;Frontiers in Chemical Engineering;2024-08-29
4. Fenamates: Forgotten treasure for cancer treatment and prevention: Mechanisms of action, structural modification, and bright future;Medicinal Research Reviews;2024-08-22
5. Advancing drug discovery with deep attention neural networks;Drug Discovery Today;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3